UnitedHealth Group Faces Criminal Investigation for Potential Medicare Fraud
By Smart Money Mindset Staff
Date: May 15, 2025
UnitedHealth Group Inc., one of the largest health insurers in the United States, is reportedly under investigation by the U.S. Department of Justice (DOJ) for potential Medicare fraud, particularly concerning its Medicare Advantage business. This probe adds to the turmoil the company is currently experiencing, following recent leadership changes and a significant drop in its stock price.
Criminal Investigation Reported
According to a report by The Wall Street Journal, the DOJ’s healthcare-fraud unit is overseeing the investigation, which appears to be focused on the business practices of UnitedHealth’s Medicare Advantage program. This program allows private insurers to provide Medicare benefits to elderly and disabled Americans, who number nearly 65 million.
While the specifics of the allegations remain unclear, the investigation has reportedly been ongoing since at least last summer. The Wall Street Journal noted that UnitedHealth had not been formally notified about the criminal inquiry. In a statement, the company reaffirmed the integrity of its Medicare Advantage program, asserting that it has not engaged in any fraudulent activities.
Impact on Stock and Leadership
Following the news of the investigation, UnitedHealth’s stock fell by approximately 8% in after-hours trading. This is part of a broader trend; just a day earlier, the company acknowledged its struggles as it also suspended its financial forecast for 2025 due to rising medical costs. As a result, shares had already plunged by nearly 18%, reaching a four-year low.
The upheaval at UnitedHealth has escalated with the unexpected resignation of CEO Andrew Witty, which was announced concurrently with the suspension of the financial outlook. Former CEO Stephen Hemsley, who had led the company until 2017, has returned to resume his leadership role during this challenging period.
Broader Context of Scrutiny
UnitedHealth has faced increasing scrutiny in recent months. Earlier this year, U.S. Senator Chuck Grassley initiated an inquiry into the company’s Medicare billing practices, requesting extensive documentation concerning its compliance programs. Additionally, a civil fraud investigation into the insurer’s Medicare operations was reported back in February.
The recent investigation into UnitedHealth aligns with a larger trend of investigations into the Medicare Advantage program. Notably, the DOJ has filed lawsuits against three major U.S. health insurers, alleging that they engaged in kickback schemes to incentivize brokers to direct patients into their Medicare Advantage plans.
Conclusion
As the investigation unfolds, UnitedHealth Group faces significant challenges that could have far-reaching implications for the company and its operations within the healthcare market. The company’s efforts to maintain transparency and uphold the integrity of its programs will be critical as it navigates this difficult landscape. Stakeholders will be closely monitoring the developments surrounding this criminal probe and its impact on the broader healthcare sector.